On December 5, 2024, the U.S. Food and Drug Administration (FDA or Agency) issued a draft guidance entitled Expedited Program for ...

Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the ...

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

Delhi police on Tuesday argued in the Delhi High Court that February 2020 riots were a result of “clinical and pathological conspiracy” executed with a “diabolical intention and ruthless intensity”.

Act (UAPA), the Delhi Police opposed the bail of Sharjeel Imam, Umar Khalid, and others accused in the case involving the ...

After completing Yale SOM’s MBA for Executives program, Alicia Hardy ’23, Amaziah Coleman ’24, and Steven Starks ’23 returned to their workplaces with proposals to make quality healthcare more ...

About NXC-201 NXC-201 is a sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy. Initial data from Phase 1b/2 ex-U.S. study NEXICART-1 has demonstrated high complete ...

Amandeep Salhotra, MD, discussed the background and findings from a pilot trial evaluating enasidenib as post-hematopoietic ...

Over 300 Participants Have Completed Cumulative Six Months of Cytisinicline Treatment in the ORCA-OL Trial, Completing the Long-Term Exposure ...

Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the ...

I am bullish on Veeva's growth prospects, with 40% potential upside, making it one of my top software stock picks for 2025.

Oxular began a phase 2 trial for its therapeutic candidate OXU-001, for the treatment of diabetic macular edema in October ...